Serum calprotectin and complement factor 3 may better identify systemic inflammation than CRP in patients with early psoriatic arthritis, especially those who are CRP negative or have obesity.
Researchers found that EnMax tablets safely and effectively reduce postoperative pain, inflammation (VRS), and biomarkers (CRP, ESR) in orthopedic surgery patients.